Clinical Trials
3 trialsNCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT03289273 2023-06-13
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Bayer
Completed
NCT03644511 2020-08-21
SORAGO-HCC
Bayer
Terminated